- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04378049
Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement (RoboKnees)
November 27, 2023 updated by: McMaster University
Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement: A Pilot Randomized Controlled Trial
This is a pilot randomized trial to assess the feasibility of a definitive trial to determine the effect of robot-assisted partial knee replacements versus standard total knee replacements.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Knee osteoarthritis (OA) pain is an important source of morbidity and cost to the health care system.
Over 60,000 knee replacement surgeries are performed in Canada every year, making it the second most common surgery.
Our institution (St.
Joseph's Healthcare Hamilton) is the first hospital in Canada to purchase a Mako RIO orthopaedic robot to assist with performing knee replacements.
The knee is divided into three compartments, and one, two, or all three compartments can become arthritic.
Over 90% of patients with end-stage knee OA receive a total knee replacement (also known as total knee arthroplasty or TKA) even if they have one or two healthy knee compartments.
Partial knee replacements are an option for these patients but these procedures are very technically demanding and associated with a higher risk of implant failure.
For this reason, few surgeons are experts at partial knee replacements.
We believe that we can use robotic technology to make it easier for surgeons to perform partial replacements more accurately, thereby increasing the quality and survivorship of partial knee replacements.
This may lead to better patient-important outcomes like return to activity, pain, and satisfaction, and eventually better access to high-quality partial knee replacements for Canadians.
This will be the first study to evaluate total knee replacements (standard care) versus robot-assisted partial knee replacements, and could lead to greater uptake of robotic technology in orthopaedics and a shift toward anatomy-sparing partial knee replacements.
Study Type
Interventional
Enrollment (Estimated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kim Madden, PhD
- Phone Number: 289-237-7380
- Email: maddenk@mcmaster.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 4A6
- Recruiting
- St. Joseph's Healthcare Hamilton
-
Contact:
- Kim Madden, PhD
- Email: maddenk@mcmaster.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria
- Adult (18+)
- Unicompartmental knee OA with or without concomitant patellofemoral OA, requiring surgical treatment
- Two study surgeons independently agree that the patient is eligible for either treatment group
Exclusion criteria
- Inability to provide informed consent (e.g. cognitive disability, language barrier)
- Revision knee surgery
- Simultaneous bilateral knee surgery
- Previous major knee surgery or trauma
- The robot or required components are unavailable (e.g. technical difficulties, robot-specific disposables out of stock)
- A CT scan cannot be obtained prior to surgery
- Patient does not wish to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard total knee arthroplasty
Participants who are randomized to the control group will undergo TKA according to local standard of care.
The choice of implant and use of bone cement will be recorded but left to the surgeon's discretion according to their standard practice.
|
Surgeon will perform a total knee arthroplasty procedure according to local standard of care
Other Names:
|
Experimental: Robot-assisted partial knee arthroplasty
Participants with isolated medial or isolated lateral compartment OA who are randomized to the intervention group and have one affected knee compartment will receive a robot-assisted unicompartmental knee arthroplasty (UKA).
If the patient has medial or lateral OA plus patellofemoral OA they will receive a bicompartmental knee arthroplasty (BiKA) consisting of a two simultaneous UKAs.
The partial knee replacement procedures will be performed using the Mako RIO robotic arm (Stryker) according to the manufacturer's instructions.
The choice of implant and use of bone cement will be recorded but will be left to the surgeon's discretion.
Surgeons will resurface the patella if the patellar cartilage meets Outerbridge grade 3 or 4 criteria
|
Surgeon will perform a robot-assisted unicompartmental or bicompartmental knee arthroplasty procedure
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility- Recruitment
Time Frame: 12 months
|
The number of patients recruited during a 12 month period
|
12 months
|
Feasibility- Participant retention
Time Frame: 12 months
|
Number of patients completing the study
|
12 months
|
Feasibility- Treatment compliance
Time Frame: 12 months
|
The number of crossovers during a 12 month period
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Return to function questionnaire
Time Frame: 12 months post-surgery
|
We will use the 5-item Return To Function (RTF) questionnaire to determine when a trial participant returns to work, leisure, and activities around the home after an injury or surgery (measured as time to return to unrestricted activities).
|
12 months post-surgery
|
Oxford knee score
Time Frame: 12 months post-surgery
|
We will measure knee function using the Oxford Knee Score (OKS), which is a validated and well-used 12 item questionnaire used to measure knee function when performing daily activities after total knee replacement surgery.
The OKS is scored on a 0-48 scale with higher scores representing a better outcome.
|
12 months post-surgery
|
Forgotten joint score
Time Frame: 12 months post-surgery
|
We will use the Forgotten Joint Score (FJS-Knee) to measure how natural the replaced knee feels.
The FJS-Knee is a 12 item questionnaire that aims to assess both function and feeling by asking about patients' awareness of their artificial knee while doing various daily activities.
The FJS is scored on a 0-100 scale with higher scores representing a better outcome.
|
12 months post-surgery
|
Gait walking mechanics analysis
Time Frame: 12 months post-surgery
|
Overground walking kinematic gait analysis will be performed in the clinic environment using a ten-camera optoelectronic motion capture system.
Primary gait outcomes will include the knee joint flexion and adduction angle magnitudes and range during the stance phase of gait.
Secondary gait outcomes will include stride characteristics as defined above, knee transverse rotation during stance, knee flexion during swing, hip and ankle range of motion and peak magnitudes during stance.
|
12 months post-surgery
|
Quality of life- EQ-5D
Time Frame: 12 months post-surgery
|
We will use the Euro-Qol 5 Dimensions (EQ-5D) questionnaire, a widely used and well-validated quality of life tool, to measure participant quality of life.
The EQ-5D is a comprehensive, 5-item compact health status classification and health state preference questionnaire.
|
12 months post-surgery
|
Persistent post-surgical pain (PPSP)
Time Frame: 12 months post-surgery
|
We will use a modified version of the WHO's definition of PPSP, to include a minimum threshold of pain severity:
|
12 months post-surgery
|
Patient global impression of change score
Time Frame: 12 months post-surgery
|
We will use The Patient Global Impression of Change (PGIC) scale to assess patients' beliefs about the efficacy of treatment.
The PGIC is one item and asks patients to rate the effectiveness of the treatment of interest on a 7-point ordinal scale ranging from "very much improved" to "very much worse
|
12 months post-surgery
|
Healthcare resource use (for cost-effectiveness)
Time Frame: 12 months post-surgery
|
We will collect healthcare resource utilization information (e.g.
hospitalization, physician visits) and information on productivity (e.g.
time missed from work) to assist with health economic analyses.
|
12 months post-surgery
|
Rage of motion (ROM)
Time Frame: 6 weeks post-surgery
|
We will measure knee ROM using a goniometer at in-clinic visits according to standard practice
|
6 weeks post-surgery
|
Knee alignment
Time Frame: Post-surgery
|
We will measure mechanical alignment on pre-operative and post-operative weightbearing x-rays
|
Post-surgery
|
Adverse events
Time Frame: 12 months post-surgery
|
We will collect all serious adverse events and surgery-related non-serious adverse events throughout the trial for safety monitoring purposes
|
12 months post-surgery
|
Short-term implant survival
Time Frame: 12 months post-surgery
|
We will report the number of revision surgeries within the study period including cases of periprosthetic joint infection, aseptic loosening, instability, poly wear, intractable pain, periprosthetic fracture etc.
|
12 months post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Anthony Adili, MD, P.Eng, FRCSC, McMaster University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 23, 2020
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
May 4, 2020
First Submitted That Met QC Criteria
May 4, 2020
First Posted (Actual)
May 7, 2020
Study Record Updates
Last Update Posted (Actual)
November 28, 2023
Last Update Submitted That Met QC Criteria
November 27, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RoboKnees
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We will share data upon reasonable request for non-commercial purposes.
This may require an institutional data-sharing agreement.
IPD Sharing Time Frame
Upon study completion.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on Total knee arthroplasty
-
Technische Universität DresdenActive, not recruiting
-
Technische Universität DresdenMathys Ltd BettlachUnknownKnee Osteoarthritis
-
Jesus Moreta SuarezActive, not recruiting
-
Chang Gung Memorial HospitalUnknownComputer-assisted Navigation Versus Conventional Total Knee ReplacementTaiwan
-
Smith & Nephew, Inc.TerminatedDegenerative Arthritis of KneeUnited States, Australia
-
Technische Universität DresdenAesculap AGCompletedOsteoarthritis | Metal Ion LevelsGermany
-
MAKO Surgical Corp.CompletedOsteoarthritis | Rheumatoid Arthritis | Post-traumatic ArthritisUnited States
-
Singapore General HospitalCompleted
-
Nova Scotia Health AuthorityUnknown
-
Aesculap AGB.Braun Surgical SAActive, not recruitingKnee Osteoarthritis | Prosthesis-Related Infections | Prosthesis Failure | Bone; Deformity, CongenitalSpain